CCCC — C4 THERAPEUTICS INC
As of Q2 2026, 28 SEC-registered investment managers reported holding CCCC (C4 THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $216.69M across 46.88M shares. That is +55.1% by share count (+16.66M shares) versus the previous quarter, while reported value moved +173.3%. Ownership is concentrated: the five largest holders account for 62.5% of reported value and the top ten for 87.5%.
Compared with the prior quarter, 6 opened new positions, 17 added to existing stakes, 5 trimmed, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
CCCC is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Morgan Stanley history | Q2 2026 | 8.87M | $41.41M | 0.00% | Reduce |
| BlackRock Inc history | Q2 2026 | 7.90M | $36.88M | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 4.75M | $20.65M | 0.00% | New |
| Citadel Advisors history | Q2 2026 | 4.28M | $20.01M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 3.53M | $16.49M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 3.47M | $16.20M | 0.01% | Add |
| Bank of America Corp history | Q2 2026 | 2.66M | $12.41M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 2.52M | $11.78M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 4.38M | $8.37M | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 1.74M | $8.13M | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 1.19M | $5.56M | 0.01% | Reduce |
| Northern Trust Corp history | Q2 2026 | 1.16M | $5.42M | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 894.05K | $4.18M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 828.97K | $3.87M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 781.06K | $3.65M | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 452.70K | $2.11M | 0.00% | Reduce |
| Invesco Ltd history | Q2 2026 | 290.23K | $1.36M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 249.52K | $1.17M | 0.00% | New |
| Wellington Management Group history | Q2 2026 | 227.77K | $1.06M | 0.00% | New |
| Marshall Wace history | Q2 2026 | 227.00K | $1.06M | 0.00% | Add |
New Positions (Q2 2026)
- JPMorgan Chase & Co 4.75M sh · $20.65M
- BNY Mellon 249.52K sh · $1.17M
- Wellington Management Group 227.77K sh · $1.06M
- Deutsche Bank AG 98.87K sh · $461.74K
- Manulife Financial 27.51K sh · $128.49K
- Legal & General Investment Management America 9.83K sh · $45.92K
Fully Exited (vs previous quarter)
- Farallon Capital Management sold 28.00K sh · $73.64K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley | 290.10K | 918.47K | 657.57K | 455.46K | 344.39K | 379.20K | 294.14K | 241.04K | 313.08K | 205.34K | 514.18K | 1.14M | 2.33M | 3.84M | 4.05M | 4.75M | 4.97M | 8.98M | 9.07M | 8.87M |
| BlackRock Inc | — | — | — | — | — | — | — | — | — | — | — | — | 4.89M | 5.56M | 5.28M | 1.83M | 1.60M | 1.97M | 2.05M | 7.90M |
| JPMorgan Chase & Co | 54.83K | 28.72K | 69.42K | 24.78K | 26.36K | 100.48K | 1.64K | 1.50K | 9.13K | 6.89K | 6 | 24.99K | 25.78K | 33.41K | 34.42K | 4.61K | 4.43K | 5.95K | — | 4.75M |
| Citadel Advisors | 47.44K | 180.46K | 142.93K | 39.15K | 145.39K | 392.60K | 559.05K | 703.08K | 418.24K | 353.11K | 542.62K | 531.56K | 137.90K | 157.42K | — | — | 535.85K | 498.61K | 2.59M | 4.28M |
| Goldman Sachs Group | 263.96K | 224.85K | 119.79K | 131.72K | 420.84K | 283.95K | 345.58K | 230.57K | 218.72K | 113.51K | 1.28M | 737.84K | 505.85K | 573.65K | 622.72K | 880.26K | 459.89K | 1.09M | 2.39M | 3.53M |
| Two Sigma Investments | 21.07K | — | 114.93K | 333.89K | 195.76K | 118.28K | 263.26K | 569.08K | 402.53K | — | 1.17M | 1.31M | 828.49K | 563.84K | 514.60K | 683.60K | 834.73K | 1.51M | 3.04M | 3.47M |
| Bank of America Corp | 21.55K | 101.67K | 103.78K | 61.51K | 139.19K | 195.16K | 51.49K | 33.67K | 45.34K | 1.68M | 1.86M | 1.77M | 2.04M | 1.68M | 1.99M | 2.01M | 2.05M | 2.39M | 2.36M | 2.66M |
| Geode Capital Management | 666.32K | 686.18K | 667.82K | 721.42K | 777.22K | 797.29K | 840.78K | 438.96K | 455.84K | 482.29K | 510.31K | 1.36M | 1.37M | 1.38M | 1.43M | 745.05K | 725.30K | 988.88K | 951.04K | 2.52M |
| D. E. Shaw & Co | 9.88K | 25.73K | — | 78.79K | 130.08K | 85.96K | 194.16K | 519.18K | 434.11K | 243.64K | 496.54K | 356.21K | 118.89K | 76.48K | 79.28K | 89.47K | 11.86K | 52.88K | 1.06M | 1.74M |
| Renaissance Technologies | — | 31.30K | — | 11.50K | 62.80K | 32.50K | 326.08K | 516.90K | 357.99K | 424.70K | 405.80K | 235.20K | — | — | 214.50K | 1.09M | 936.95K | 1.60M | 2.46M | 1.19M |
| Northern Trust Corp | 363.95K | 361.70K | 349.26K | 370.52K | 381.98K | 399.03K | 384.60K | 91.16K | 90.99K | 108.68K | 108.68K | 179.57K | 489.82K | 495.04K | 499.77K | 139.67K | 138.32K | 166.21K | 189.48K | 1.16M |
| Fidelity Management & Research (FMR) | 648.98K | 648.98K | 599.28K | 1.31K | 57.52K | 52.34K | 55.10K | 54.77K | 121.17K | 37.56K | 37.29K | 23.63K | 185.94K | 218.37K | 193.75K | 201.36K | 211.35K | 254.41K | 272.37K | 894.05K |
| UBS Group AG | 417.35K | 342.80K | 329.58K | 377.19K | 317.05K | 270.22K | 162.65K | 269.80K | 321.61K | 278.38K | 696.68K | 404.12K | 334.08K | 757.85K | 872.77K | 572.03K | 61.65K | 52.75K | 215.88K | 828.97K |
| Charles Schwab Investment Management | 260.45K | 264.65K | 273.14K | 273.19K | 352.12K | 356.65K | 317.01K | 231.03K | 248.25K | 252.71K | 267.43K | 488.96K | 482.93K | 486.37K | 474.84K | 331.90K | 350.61K | 449.43K | 452.23K | 781.06K |
| Wells Fargo & Co | 28.38K | 31.23K | 18.78K | 502 | 6.21K | — | 7.49K | 311 | 334 | 1.30K | 358 | 25.76K | 26.92K | 36.31K | 523.62K | 1.53K | 18.66K | 809.26K | 867.91K | 452.70K |
| Invesco Ltd | 470.52K | 464.20K | 138.41K | 13.86K | 16.26K | 16.23K | 69.46K | 55.91K | 56.39K | 692.08K | 38.54K | 65.50K | 64.55K | 69.19K | 139.49K | 155.02K | 191.82K | 268.35K | 244.51K | 290.23K |
| BNY Mellon | 112.60K | 125.47K | 127.07K | 133.50K | 151.84K | 152.50K | 151.56K | 22.28K | 20.87K | 20.68K | — | 190.76K | 143.29K | 141.08K | 141.28K | — | — | — | — | 249.52K |
| Wellington Management Group | — | — | — | — | 67.60K | 134.78K | 124.81K | — | — | — | 197.11K | 229.34K | 286.04K | 283.70K | — | — | — | — | — | 227.77K |
| Marshall Wace | — | — | — | 252.33K | — | — | 113.24K | — | — | 1.12M | 146.64K | — | 225.42K | 36.17K | — | — | 106.28K | 265.03K | 155.50K | 227.00K |
| Millennium Management | 287.57K | 753.39K | 1.24M | 425.65K | — | — | 153.56K | 2.14M | 1.17M | 757.14K | 575.13K | 509.41K | 21.85K | 360.12K | 65.90K | 1.10M | 2.02M | 1.19M | 1.39M | 215.39K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details